Clinical Trial Update: Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating fluorouracil-uracil and leucovorin for metastatic breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• uracil (uracil)

Snippet

Sponsor: Northwestern University | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED